Atherosclerosis Newswire

Atherosclerosis Newswire

Comprehensive Real-Time News Feed for Atherosclerosis.

Results 1 - 20 of 28 in Atherosclerosis

  1. MicroRNA-150 is Important in the Contribution of Macrophages to Age-Related DiseaseRead the original story

    Tuesday Apr 10 | Fight Aging!

    ... to the pathogenesis of numerous diseases of aging, including age-related macular degeneration (AMD) and atherosclerosis . In addition, age-associated changes in microglia , the major resident immune cell in the retina with similar phagocytic ...

    Comment?

  2. Statins in Peripheral Artery Disease [Editorials]Read the original story w/Photo

    Monday Apr 2 | Circulation

    ... as amputation, and reduce the risk of other major cardiovascular events that are common among patients with atherosclerosis, as well. Unfortunately, much of the data regarding lipid-lowering therapy for PAD have been extrapolated from studies of ...

    Comment?

  3. Carotid Atherosclerosis Progression in Familial Hypercholesterolemia...Read the original story w/Photo

    Jul 1, 2010 | Circulation

    Background- Until recently, patients with heterozygous familial hypercholesterolemia were considered the best subjects for the assessment of changes in carotid intima-media thickness in randomized intervention trials. Our aims were to investigate whether contemporary statin-treated HeFH patients still show accelerated cIMT increase and to assess the impact of statin treatment, before and after random assignment, on atherosclerosis progression.

    Comment?

  4. Dumaguing: Ezetimibe helps control cholesterolRead the original story w/Photo

    Wednesday Mar 28 | Sun-Star

    CHOLESTEROL was the cynosure of attention during the recently concluded Asian Pacific Society of Atherosclerosis and Vascular Diseases at the Iloilo Convention Center and was again a main focus at the annual meeting of the Philippine Society of Endocrinology and Metabolism held at the EDSA Shangri-La on March 22 to 24, 2018. Why all this fuss about cholesterol? Understandably, everybody, in fact, even school children, have this very negative attitude towards cholesterol and for good reasons.

    Comment?

  5. 'Statins in retinal disease'Read the original story w/Photo

    Mar 20, 2018 | Eye

    ... CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis . 1999;147:237-42. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al. Effect of pravastatin on ...

    Comment?

  6. Amgen To Present New Data From Repatha (evolocumab) Clinical Trials At ACC.18Read the original story

    Feb 26, 2018 | Digital Post Production

    ... of Research and Development at Amgen. "We look forward to sharing data showing the likelihood of coronary atherosclerosis regression with Repatha treatment, as well as results from the Repatha cardiovascular outcomes study evaluating efficacy in ...

    Comment?

  7. Protecting Life and Limb in Peripheral Artery Disease [Editorials]Read the original story w/Photo

    Jan 22, 2018 | Circulation

    ... persons in the United States and >200 million persons worldwide. As a clinical manifestation of systemic atherosclerosis, it has a foreboding prognosis because it often coexists with coronary artery disease or cerebrovascular disease. The risk of ...

    Comment?

  8. The gene-treatment interaction of paraoxonase-1 gene polymorphism...Read the original story w/Photo

    Dec 11, 2017 | BioMed Central

    ... inhibitors (statins) is an important and recommended therapy to reduce cardiovascular risk and to treat atherosclerosis associated with hypercholesterolemia [ ]. Recently, however, several studies have reported adverse effects of statins on glucose ...

    Comment?

  9. Anti-inflammatory evaluation of the methanolic extract of Taraxacum...Read the original story w/Photo

    Nov 28, 2017 | BioMed Central

    Atherosclerosis is a chronic vascular inflammatory disease. Since even low-level endotoxemia constitutes a powerful and independent risk factor for the development of atherosclerosis, it is important to find therapies directed against the vascular effects of endotoxin to prevent atherosclerosis.

    Comment?

  10. Naturally occurring molecule may help prevent and treat atherosclerosis and gum diseaseRead the original story w/Photo

    Nov 16, 2017 | PhysOrg Weblog

    Resolvin E1, a molecule produced naturally in the body from an omega -3 fish oil, topically applied on gum tissues not only prevents and treats gum disease as previously shown , but also decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a dangerous thrombus or blood clot. The findings, which appear in the journal Current Atherosclerosis Reports, could lead to effective preventive and therapeutic treatments in people with heart disease and/or gum disease without unwanted side effects.

    Comment?

  11. Naturally occurring molecule may help prevent and treat atherosclerosis and gum diseaseRead the original story w/Photo

    Nov 15, 2017 | EurekAlert!

    Resolvin E1, a molecule produced naturally in the body from an omega -3 fish oil, topically applied on gum tissues not only prevents and treats gum disease as previously shown , but also decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a dangerous thrombus or blood clot. The findings, which appear in the journal Current Atherosclerosis Reports, could lead to effective preventive and therapeutic treatments in people with heart disease and/or gum disease without unwanted side effects.

    Comment?

  12. Scientists develop a drug that can 'melt away fat' and REVERSE heart...Read the original story w/Photo

    Nov 3, 2017 | Daily Star

    Researchers from the University of Aberdeen have found that a single does of the new drug completely reversed the effects of atherosclerosis a disease that can cause a variety of heart problems. Here we break down the changes that occur in your body within minutes, hours, days, and even years after you kick the habit.

    Comment?

  13. Anti-cancer drugs could help prevent the hardening of blood vessels...Read the original story

    Oct 25, 2017 | PressReleasePoint

    Drugs already in clinical trials for the treatment of cancers could be repurposed to prevent atherosclerosis - the build-up of fatty plaques. Anti-cancer drugs could prevent the build-up of fatty plaques in blood vessels which cause heart attack and stroke, a new study by the University of Sheffield has shown.

    Comment?

  14. Anti-cancer drugs could prevent the hardening of blood vessels that cause heart attack and strokeRead the original story w/Photo

    Oct 25, 2017 | PhysOrg Weblog

    Anti-cancer drugs could prevent the build-up of fatty plaques in blood vessels which cause heart attack and stroke, a new study by the University of Sheffield has shown. The new research, funded by the British Heart Foundation, suggests drugs which are already in clinical trials for the treatment of cancers could be repurposed to prevent atherosclerosis - the build-up of fatty plaques which can lead to heart attack and stroke.

    Comment?

  15. Frontier Pharma Cardiovascular Disease Global Key Market Developments ...Read the original story

    Oct 18, 2017 | Emailwire.com

    ... First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis For more information about this report: ...

    Comment?

  16. Arcus senilis: Causes, symptoms, and treatmentRead the original story w/Photo

    Sep 22, 2017 | Medical News Today

    ... check the thickness of the vessels for increased levels of fat deposits. They will also look for signs of atherosclerosis , which is a condition where arteries become clogged with fatty substances. If both arcus senilis and atherosclerosis are ...

    Comment?

  17. Quantifying the Benefits of Statins over the Long TermRead the original story

    Sep 7, 2017 | Fight Aging!

    ... by statins is one in which lipids oxidized due to other mechanisms of aging drive the pace at which atherosclerosis progresses. Lowering overall lipid levels in the bloodstream also lowers the level of these problem damaged molecules, and so ...

    Comment?

  18. Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class...Read the original story

    Sep 4, 2017 | Customer Interaction Solutions

    Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis - Research and Markets Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis - Research and Markets Cardiovascular disease is a broad therapy area containing a range of indications relating to the human vasculature, heart and lipid levels. There is considerable first-in-class innovation within the CVD pipeline, comparable with the industry average.

    Comment?

  19. The 2017 Summer Scholars Working at the SENS Research FoundationRead the original story

    Aug 25, 2017 | Fight Aging!

    ... walls, becoming part of the problem instead of the solution and contributing to the plaques which cause atherosclerosis , or hardening of the arteries. In order to develop a safer, more effective treatment for atherosclerosis, a rational drug design ...

    Comment?

  20. Discovery of a Highly Potent, Selective, and Metabolically Stable...Read the original story

    Aug 15, 2017 | CiteULike

    ... disease pathology, cell necrosis has gradually been verified as a promising therapeutic target for treating atherosclerosis, systemic inflammatory response syndrome (SIRS), and ischemia injury, among other diseases. Most necrosis inhibitors ...

    Comment?